Author Question: On which of the following pharmacological dimensions does cannabis (delta-9-THC) differ ... (Read 36 times)

scienceeasy

  • Hero Member
  • *****
  • Posts: 565
On which of the following pharmacological dimensions does cannabis (delta-9-THC) differ significantly from LSD, psilocybin and mescaline?
 
  a. the degree to which they induce profound and intense perceptual distortions and hallucinatory experiences
  b. their effects on wakefulness
  c. the rate at which tolerance develops to their subjective effects
  d. all of these

Question 2

The major psychoactive compound in marijuana, delta-9-THC, has actions mediated by CB1 receptors. An endogenous ligand for this class of receptors is called
 
  a. dopamine
  b. serotonin
  c. acetylcholine
  d. anandamide



xiaomengxian

  • Sr. Member
  • ****
  • Posts: 311
Answer to Question 1

d

Answer to Question 2

d



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Calcitonin is a naturally occurring hormone. In women who are at least 5 years beyond menopause, it slows bone loss and increases spinal bone density.

Did you know?

According to the Migraine Research Foundation, migraines are the third most prevalent illness in the world. Women are most affected (18%), followed by children of both sexes (10%), and men (6%).

Did you know?

Colchicine is a highly poisonous alkaloid originally extracted from a type of saffron plant that is used mainly to treat gout.

Did you know?

Liver spots have nothing whatsoever to do with the liver. They are a type of freckles commonly seen in older adults who have been out in the sun without sufficient sunscreen.

Did you know?

Hyperthyroidism leads to an increased rate of metabolism and affects about 1% of women but only 0.1% of men. For most people, this increased metabolic rate causes the thyroid gland to become enlarged (known as a goiter).

For a complete list of videos, visit our video library